After finishing at $4.14 in the prior trading day, Aurora Cannabis Inc (NASDAQ: ACB) closed at $4.21, up 1.69%. In other words, the price has increased by $+0.0700 from its previous closing price. On the day, 8496802 shares were traded.
Ratios:
Our goal is to gain a better understanding of ACB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 228.37M and an Enterprise Value of 195.16M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 0.51. Its current Enterprise Value per Revenue stands at 0.92 whereas that against EBITDA is -0.12.
Stock Price History:
The Beta on a monthly basis for ACB is 2.33, which has changed by -38.72% over the last 52 weeks, in comparison to a change of 29.19% over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $2.84. The 50-Day Moving Average of the stock is 3.6974, while the 200-Day Moving Average is calculated to be 4.8988.
Shares Statistics:
The stock has traded on average 1.42M shares per day over the past 3-months and 5.11M shares per day over the last 10 days, according to various share statistics. A total of 34.53M shares are outstanding, with a floating share count of 15.59M. Insiders hold about 0.88% of the company’s shares, while institutions hold 30.36% stake in the company. Shares short for ACB as of Feb 29, 2024 were 3.55M with a Short Ratio of 2.51, compared to 3.62M on Jan 31, 2024.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.29, while EPS last year was -$1.47. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.62 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.32, with 3 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
4 analysts predict $51.5M in revenue for the current quarter. It ranges from a high estimate of $53.5M to a low estimate of $50.69M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 9.90% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $235.29M in the next fiscal year. The high estimate is $248.29M and the low estimate is $223.1M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.
